Erber R - Search Results

1

Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041).

Fasching PA, Hein A, Kolberg HC, Häberle L, Uhrig S, Rübner M, Belleville E, Hack CC, Fehm TN, Janni W, Hartmann A, Erber R, Theuser AK, Brucker SY, Hartkopf AD, Untch M. Fasching PA, et al. Among authors: erber r. Eur J Cancer. 2023 May;184:1-9. doi: 10.1016/j.ejca.2023.01.001. Epub 2023 Jan 9. Eur J Cancer. 2023. PMID: 36871424 Free article. Clinical Trial.

2

Adenomatoid Tumor of the Uterus: A Report of 6 Unusual Cases With Prominent Cysts Including 4 With Diffuse Myometrial Involvement, 4 With Uterine Serosal Involvement, and 2 Presenting in Curettage Specimens.

Lerias S, Ariyasriwatana C, Agaimy A, Erber R, Young RH, Oliva E. Lerias S, et al. Among authors: erber r. Int J Gynecol Pathol. 2021 May 1;40(3):248-256. doi: 10.1097/PGP.0000000000000685. Int J Gynecol Pathol. 2021. PMID: 32897967

3

Aberrant p21(CIP1/WAF1) protein accumulation in head-and-neck cancer.

Erber R, Klein W, Andl T, Enders C, Born AI, Conradt C, Bartek J, Bosch FX. Erber R, et al. Int J Cancer. 1997 Aug 22;74(4):383-9. doi: 10.1002/(sici)1097-0215(19970822)74:4<383::aid-ijc4>3.0.co;2-r. Int J Cancer. 1997. PMID: 9291426 Free article.

4

Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control.

Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, Klein W, Helbig M, Dietz A, Weidauer H, Bosch FX. Andl T, et al. Among authors: erber r. Cancer Res. 1998 Jan 1;58(1):5-13. Cancer Res. 1998. PMID: 9426048

5

[p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas].

Bosch FX, Homann N, Conradt C, Dietz A, Erber R. Bosch FX, et al. Among authors: erber r. HNO. 1999 Sep;47(9):833-48. doi: 10.1007/s001060050470. HNO. 1999. PMID: 10525616 Review. German. No abstract available.

6

TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer.

Erber R, Conradt C, Homann N, Enders C, Finckh M, Dietz A, Weidauer H, Bosch FX. Erber R, et al. Oncogene. 1998 Apr 2;16(13):1671-9. doi: 10.1038/sj.onc.1201690. Oncogene. 1998. PMID: 9582015

7

Evidence that wild-type p53 in neuroblastoma cells is in a conformation refractory to integration into the transcriptional complex.

Wolff A, Technau A, Ihling C, Technau-Ihling K, Erber R, Bosch FX, Brandner G. Wolff A, et al. Among authors: erber r. Oncogene. 2001 Mar 15;20(11):1307-17. doi: 10.1038/sj.onc.1204251. Oncogene. 2001. PMID: 11313875

8

Altered levels of urokinase on monocytes and in serum of children with AIDS; effects on lymphocyte activation and surface marker expression.

Murali R, Wolfe JH, Erber R, Chice SM, Murali MR, Durkin HG, Zach P, Auci DL. Murali R, et al. Among authors: erber r. J Leukoc Biol. 1998 Aug;64(2):198-202. doi: 10.1002/jlb.64.2.198. J Leukoc Biol. 1998. PMID: 9715259

9

Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression.

Nitz U, Gluz O, Huober J, Kreipe HH, Kates RE, Hartmann A, Erber R, Moustafa Z, Scholz M, Lisboa B, Mohrmann S, Möbus V, Augustin D, Hoffmann G, Weiss E, Böhmer S, Kreienberg R, Du Bois A, Sattler D, Thomssen C, Kiechle M, Jänicke F, Wallwiener D, Harbeck N, Kuhn W. Nitz U, et al. Among authors: erber r. Ann Oncol. 2014 Aug;25(8):1551-7. doi: 10.1093/annonc/mdu186. Epub 2014 May 14. Ann Oncol. 2014. PMID: 24827128 Free article. Clinical Trial.

10

Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial.

Erber R, Gluz O, Brünner N, Kreipe HH, Pelz E, Kates R, Bartels A, Huober J, Mohrmann S, Moustafa Z, Liedtke C, Möbus V, Augustin D, Thomssen C, Jänicke F, Kiechle M, Kuhn W, Nitz U, Harbeck N, Hartmann A. Erber R, et al. Breast Cancer Res Treat. 2015 Apr;150(2):279-88. doi: 10.1007/s10549-015-3310-x. Epub 2015 Feb 28. Breast Cancer Res Treat. 2015. PMID: 25721604 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page